Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative omics directed gene discovery and rewiring for normal temperature-adaptive red pigment synthesis by polar psychrotrophic fungus <i>Geomyces</i> sp. WNF-15A.

Synthetic and systems biotechnology·2024
Same author

OBHSA, a novel selective estrogen receptor degrader, overcomes tamoxifen resistance through cell cycle arrest and unfolded protein response-mediated apoptosis in breast cancer.

The Journal of steroid biochemistry and molecular biology·2024
Same author

Sigma-1 receptor exerts protective effects on ameliorating nephrolithiasis by modulating endoplasmic reticulum-mitochondrion association and inhibiting endoplasmic reticulum stress-induced apoptosis in renal tubular epithelial cells.

Redox report : communications in free radical research·2024
Same author

SPP1 promotes the polarization of M2 macrophages through the Jak2/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis.

International journal of molecular medicine·2024
Same author

Machine learning and 4D-LFQ quantitative proteomic analysis explore the molecular mechanism of kidney stone formation.

Heliyon·2024
Same author

Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients.

Frontiers in oncology·2024

Related Experiment Video

Updated: Aug 8, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.

Jianfeng Lin1, Jiawei Zhou1, Yan Xu2,3

  • 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, PR China.

Brain : a Journal of Neurology
|March 3, 2023
PubMed
Summary

This study identifies five proteins—FCRL3, TYMP, AHSG, MMEL1, and SLAMF7—as potential causal factors and novel drug targets for multiple sclerosis (MS) prevention. These findings offer new avenues for developing more effective MS therapies.

Keywords:
Mendelian randomizationdrug targetmultiple sclerosis

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

914
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Related Experiment Videos

Last Updated: Aug 8, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

914
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Area of Science:

  • Genetics and Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a complex autoimmune disease with current therapies showing limitations in preventing relapses and disease progression.
  • There is a critical need for novel drug targets to improve the prevention and treatment of multiple sclerosis.
  • Mendelian randomization (MR) is a powerful genetic epidemiology method for inferring causal relationships.

Purpose of the Study:

  • To identify potential causal proteins and novel drug targets for multiple sclerosis (MS) using a large-scale Mendelian randomization study.
  • To explore the causal effect of genetically determined protein levels on MS risk.
  • To investigate the potential of identified proteins as therapeutic targets for MS.

Main Methods:

  • Performed Mendelian randomization (MR) analysis using summary statistics from large MS genetic consortia and replication in UK Biobank and FinnGen.
  • Utilized genetic instruments for plasma and cerebrospinal fluid (CSF) proteins.
  • Employed bidirectional MR, Steiger filtering, Bayesian co-localization, and protein-protein interaction networks to validate findings and explore drug target interactions.

Main Results:

  • Identified six protein-MS pairs at Bonferroni significance, with FCRL3, TYMP, and AHSG (plasma) showing protective effects, and MMEL1 (CSF) increasing risk, while SLAMF7 and CD5L (CSF) decreased risk.
  • Confirmed causal effects for FCRL3, TYMP, AHSG, MMEL1, and SLAMF7, with no evidence of reverse causality.
  • Found that FCRL3, TYMP, and SLAMF7 interact with targets of existing MS medications, and MMEL1 was replicated across cohorts.

Conclusions:

  • Genetically determined levels of circulating FCRL3, TYMP, AHSG, CSF MMEL1, and CSF SLAMF7 causally influence multiple sclerosis risk.
  • These five proteins represent promising novel drug targets for multiple sclerosis prevention and treatment.
  • Further clinical investigation, particularly for FCRL3 and SLAMF7, is warranted to explore their therapeutic potential in MS.